173 related articles for article (PubMed ID: 12819814)
1. Pharmacogenetics in psychosis.
Collier DA
Drug News Perspect; 2003 Apr; 16(3):159-65. PubMed ID: 12819814
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics as a tool in the therapy of schizophrenia.
Wilffert B; Zaal R; Brouwers JR
Pharm World Sci; 2005 Feb; 27(1):20-30. PubMed ID: 15861931
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics in schizophrenia: the quest for individualized therapy.
Basile VS; Masellis M; Potkin SG; Kennedy JL
Hum Mol Genet; 2002 Oct; 11(20):2517-30. PubMed ID: 12351588
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and antipsychotic treatment response.
Naumovska Z; Nestorovska AK; Filipce A; Sterjev Z; Brezovska K; Dimovski A; Suturkova LJ
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):53-67. PubMed ID: 26076775
[TBL] [Abstract][Full Text] [Related]
6. Weight gain induced by clozapine.
Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
Eur Neuropsychopharmacol; 1995 Dec; 5(4):437-40. PubMed ID: 8998394
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in schizophrenia: a review of clozapine studies.
Kohlrausch FB
Braz J Psychiatry; 2013; 35(3):305-17. PubMed ID: 24142094
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of psychotropic drug response.
Malhotra AK; Murphy GM; Kennedy JL
Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
[TBL] [Abstract][Full Text] [Related]
9. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment.
Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ
Hum Psychopharmacol; 2010; 25(4):303-9. PubMed ID: 20521320
[TBL] [Abstract][Full Text] [Related]
10. Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol.
Rosenheck R; Chang S; Choe Y; Cramer J; Xu W; Thomas J; Henderson W; Charney D
J Clin Psychiatry; 2000 May; 61(5):382-6. PubMed ID: 10847315
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
Masellis M; Basile VS; Ozdemir V; Meltzer HY; Macciardi FM; Kennedy JL
Biol Psychiatry; 2000 Feb; 47(3):252-66. PubMed ID: 10682223
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.
Duggal HS; Mendhekar DN
Am J Psychiatry; 2006 Aug; 163(8):1449-50. PubMed ID: 16877664
[No Abstract] [Full Text] [Related]
13. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
Andia I; Zumarraga M; Zabalo MJ; Bulbena A; Davila R
Biol Psychiatry; 1998 Jan; 43(1):20-3. PubMed ID: 9442340
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
15. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
[TBL] [Abstract][Full Text] [Related]
16. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.
Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
Am J Psychiatry; 1999 Apr; 156(4):631-3. PubMed ID: 10200746
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of antipsychotics: useful for the clinician?
Bondy B; Spellmann I
Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
[TBL] [Abstract][Full Text] [Related]
18. Weight gain correlated with decrease in clozapine/N-desmethyl-clozapine ratio in a man with treatment-refractory schizophrenia.
De Mel VN; Korman N; McArdle P; Siskind DJ
Australas Psychiatry; 2018 Oct; 26(5):558-559. PubMed ID: 30269573
[No Abstract] [Full Text] [Related]
19. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
20. Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population.
Zhang XY; Tan YL; Zhou DF; Haile CN; Cao LY; Xu Q; Shen Y; Kosten TA; Kosten TR
J Clin Psychopharmacol; 2007 Jun; 27(3):246-51. PubMed ID: 17502770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
